F Haab Selected Research

F Haab Research Topics

Disease

11	Overactive Urinary Bladder (Overactive Bladder) 06/2015 - 04/2004
6	Stress Urinary Incontinence 05/2013 - 01/2001
3	Urinary Incontinence 10/2014 - 04/2011
3	Prolapse 12/2009 - 12/2009
2	Urinary Tract Infections (Urinary Tract Infection) 05/2015 - 11/2011
2	Hematuria 09/2014 - 12/2013
2	Lower Urinary Tract Symptoms 04/2013 - 12/2009
2	Pyelonephritis 08/2011 - 05/2003
2	Erectile Dysfunction 05/2011 - 12/2010
2	Neoplasms (Cancer) 12/2010 - 01/2008
2	Pelvic Organ Prolapse 12/2009 - 12/2009
2	Cystocele 12/2009 - 12/2009
2	Urge Urinary Incontinence (Urge Incontinence) 01/2006 - 03/2005
2	Constipation 01/2006 - 04/2004
2	Shock 05/2003 - 09/2000
1	Infections 05/2015
1	Weight Loss (Weight Reduction) 02/2015
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 04/2013
1	Type 2 Diabetes Mellitus (MODY) 04/2012
1	Kidney Calculi (Kidney Stone) 05/2011
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2011
1	Prostatic Neoplasms (Prostate Cancer) 12/2010
1	Pain (Aches) 12/2009
1	Respiratory Insufficiency (Respiratory Failure) 12/2009
1	Fibroma (Fibromatosis) 12/2009
1	Cicatrix (Scar) 12/2009
1	Aneurysm (Aneurysms) 12/2009
1	Dyspareunia 12/2009
1	Morbid Obesity 12/2009
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 05/2008
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2006
1	Lymphoma (Lymphomas) 01/2006
1	Renal Colic 05/2003
1	Cystitis 09/2001
1	Neoplasm Metastasis (Metastasis) 04/2001
1	Endometriosis 12/2000
1	Calculi (Calculus) 09/2000
1	Epididymitis 02/2000
1	Pathologic Constriction (Stenosis) 02/2000
1	Abscess 02/2000

Drug/Important Bio-Agent (IBA)

4	Type A Botulinum Toxins (Botox)FDA Link 06/2015 - 12/2013
3	Dexfenfluramine (Redux)IBA 12/2009 - 12/2009
2	Botulinum Toxins (Botulinum Toxin)IBA 10/2014 - 05/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2011 - 05/2003
2	Muscarinic AntagonistsIBA 01/2006 - 08/2005
2	darifenacin FDA Link 01/2006 - 04/2004
1	Neurokinin-1 Receptor AntagonistsIBA 03/2014
1	netupitantIBA 03/2014
1	Cholinergic Antagonists (Anticholinergics)IBA 04/2013
1	Antihypertensive Agents (Antihypertensives)IBA 04/2012
1	HDL CholesterolIBA 04/2012
1	Blood Glucose (Blood Sugar)IBA 04/2012
1	LipidsIBA 04/2012
1	Triglycerides (Triacylglycerol)IBA 04/2012
1	AndrogensIBA 04/2011
1	Aromatase (CYP19)IBA 04/2011
1	SteroidsIBA 04/2011
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 04/2011
1	Phosphodiesterase 5 InhibitorsIBA 12/2010
1	CollagenIBA 12/2009
1	Solifenacin Succinate FDA Link 03/2005
1	Ifosfamide FDA LinkGeneric 09/2001
1	Formaldehyde (Formol)FDA Link 09/2001
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2001
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2000

Therapy/Procedure

5	Therapeutics 02/2015 - 02/2000
4	Suburethral Slings (Tension-Free Vaginal Tape) 05/2013 - 01/2001
3	Stents 05/2015 - 02/2000
3	Injections 10/2014 - 05/2008
3	Prostatectomy (Retropubic Prostatectomy) 11/2011 - 12/2010
3	Nephrectomy 08/2011 - 01/2006
2	Urinary Catheters 09/2014 - 12/2013
2	Length of Stay 05/2011 - 12/2009
2	Lymph Node Excision (Lymph Node Dissection) 01/2008 - 04/2001
2	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 05/2003 - 09/2000
1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2011
1	Solid-State Lasers 05/2011
1	Radiotherapy 12/2010
1	Tertiary Prevention 12/2010
1	Brachytherapy 12/2010
1	Denervation 12/2009
1	Contraindications 12/2009
1	Operative Time 12/2009
1	Hysterectomy 12/2009
1	Thrombectomy 01/2008
1	Kidney Transplantation 01/2006
1	Emergency Treatment 05/2003
1	Hyperbaric Oxygenation 09/2001
1	Intravesical Administration 09/2001
1	Surgical Instruments (Clip) 04/2001